Condition

Severe Hypoglycemia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7
Recruiting4
Common interventions13
Lead sponsors shown6
Advertisement

Clinical trials

7 shown
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 DiabetesNCT07126873 · 2025-08-11
RECRUITING
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusNCT06575426 · 2025-06-10
RECRUITING
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetesNCT06770621 · 2022-05-25
RECRUITING
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 DiabetesNCT04786262 · 2021-03-29
RECRUITING
Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)NCT04863872 · 2022-01-26
COMPLETED
G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesNCT03738865 · 2018-09-27
COMPLETED
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 DiabetesNCT03439072 · 2018-01-23
COMPLETED

Trial status mix

RECRUITING4
COMPLETED3

Phase mix

PHASE33
NA2
PHASE12
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.